(Q46504932)

22 December 2017

title

Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making (English)

1 reference

22 December 2017

1 reference

Katie S Shpanskaya

3

0 references

James R Burke

object named as

James R Burke

6

0 references

author name string

Anthony S Zannas

1

1 reference

22 December 2017

P Murali Doraiswamy

2

1 reference

22 December 2017

Kelly R Murphy

4

1 reference

22 December 2017

Jeffrey R Petrella

5

1 reference

22 December 2017

Terence Z Wong

7

1 reference

22 December 2017

publication date

14 May 2013

1 reference

22 December 2017

published in

Neurocase

1 reference

22 December 2017

volume

20

1 reference

22 December 2017

page(s)

466-473

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Amyloid deposition, hypometabolism, and longitudinal cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Conversion to dementia from mild cognitive disorder: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13554794.2013.791867

10.1080/13554794.2013.791867

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

23672654

1 reference

22 December 2017